HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Gong, N. Articles by Ritter, T. Search for Related Content PubMed PubMed Citation Articles by Gong, N. Articles by Ritter, T.

Local Overexpression of Nerve Growth Factor in Rat Corneal Transplants Improves Allograft Survival

¹From the Department of Ophthalmology and the ³Institute of Medical Immunology, Charité-University Medicine, Berlin, Germany; the ²Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; ⁴Institut National de la Santé et de la Recherche Médicale U643, Institut de Transplantation et de Recherche en Transplantation, Nantes, France; the ⁵Department of Neuroimmunology, Max-Planck Institute of Neurobiology, Martinsried, Germany; and the ⁶Regenerative Medicine Institute, National University of Ireland, Galway, Ireland.

PURPOSE. To investigate the effect and mechanisms of nerve growth factor (NGF) gene therapy to promote allograft survival in experimental rat corneal transplantation.

METHODS. A rat major histocompatibility complex (MHC) class I/II disparate corneal transplant model was used. Recipients were randomly assigned to receive either local Ad (Ad)-mediated gene transfer of NGF or a single intraperitoneal injection of AdNGF 1 day before transplantation. Moreover, immunosuppressive therapy was introduced by systemic coapplication of an Ad expressing CTLA4Ig. The efficacy of this treatment was examined by intracorneal mRNA expression analysis of cytokines and cytoprotective molecules by quantitative RT-PCR at day 12 after transplant. Further graft integrity and immune response against adenoviral vectors were investigated.

RESULTS. Local AdNGF-gene transfer significantly prolonged the mean survival time (MST) of rat corneal grafts (16.8 ± 1.4 days) compared with control grafts (MST, 13.1 ± 0.3 days; P < 0.03). In contrast, systemic AdNGF gene transfer did not result in improved corneal graft survival (MST, 15.2 ± 1.0 days). RT-PCR analysis of cornea explants revealed diminished expression of proinflammatory cytokines (IFN-, TNF-) and increased expression of antiapoptotic molecules. In addition, graft endothelial integrity was improved, as measured by the detection of apoptotic cells. Moreover, coapplication of CTLA4Ig further significantly improved graft survival and protective effects of local NGF gene therapy.

CONCLUSIONS. This is the first report showing the successful application of a neurotrophin gene therapy to prolong corneal graft survival in an experimental rat transplantation model. Moreover, immunomodulatory therapy further improves graft survival and demonstrates that both anti-inflammatory and cytoprotective mechanisms are involved in the prevention of corneal allograft rejection.